To study the efficacy of levonorgestrel intrauterine system in heavy menstrual bleeding
Background: Abnormal uterine bleeding (AUB) is the commonest symptom for which women seek gynaecologist’s consultation. The excessive blood loss interferes with woman’s social, emotional, physical and material quality of life. Medical treatments are preferred primary intervention though hysterecto...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Barpeta Obstetrics and Gynaecological Society
2024-05-01
|
| Series: | New Indian Journal of OBGYN |
| Subjects: | |
| Online Access: | https://journal.barpetaogs.co.in/pdf/10429.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background: Abnormal uterine bleeding (AUB) is the commonest symptom for which women seek gynaecologist’s
consultation. The excessive blood loss interferes with woman’s social, emotional, physical and material quality of life.
Medical treatments are preferred primary intervention though hysterectomy or endometrial ablation is the treatment of
choice when medical treatment is ineffective or unacceptable. The levonorgestrel releasing intrauterine system (IUS)
is a nonsurgical, long acting, alternative to the traditional medical and surgical treatments for heavy menstrual
bleeding. Objectives: To assess the effectiveness of levonorgestrel IUS in heavy menstrual bleeding in terms of
decreased menstruation and blood loss and to follow these patients for at least 2 years. Methods: A hospital based
prospective, observational study was conducted with 35 patients from September 2019 - February 2021, to study the
efficacy of levonorgestrel intra-uterine system (LNG - IUS) in the management of heavy menstrual bleeding. LNGIUS was inserted in post menstrual phase. Follow up was done at 3, 6, 12, 24 months. At each visit blood loss,
menstrual pattern and opinion of women for satisfaction was recorded. Results: In first 3 months, 13 patients had
irregular heavy bleeding and 11 had irregular spotting. 7 achieved normal menstrual cycle and 2 had scanty menstrual
flow. During 6 months follow-up, 4 patients had irregular heavy bleeding and 3 had irregular spotting. 5 achieved
normal menstrual cycle and 13 had scanty menstrual flow. 4 patients had achieved amenorrhoea, 9 experienced
dysmenorrhoea. During 1 year follow-up, 2 patients had irregular spotting and 3 had scanty menstrual flow. 20
patients had achieved amenorrhoea while 1 experienced dysmenorrhoea. During 2 years follow-up, 1 patient had
scanty menstrual flow and 9 patients had achieved amenorrhoea. There was significant reduction in the incidence of
irregular heavy bleeding, irregular spotting and dysmenorrhoea and significantly higher number of patients achieved
amenorrhoea as per chi-square test (p<0.05). Conclusion: LNG-IUS is an effective, long acting nonsurgical treatment
for women with heavy menstrual bleeding. It can be a good alternative to hysterectomy for heavy menstrual bleeding
due to many benign etiologies. |
|---|---|
| ISSN: | 2454-2334 2454-2342 |